Abstract
The photochemistry and use of recently developed photosensitive precursors to nitric oxide (NO) are reviewed. As "caged NO" donors these precursors are able to deliver NO in a spatially and temporally controllable manner. These properties have made such precursors useful in applications in biology and medicine, especially in elucidating neurophysiological roles of NO and in new cancer therapies.
Keywords: photodynamic therapy, diazeniumdiolate, nucleophiles, photolysis, meta substituents, photorelease
Current Topics in Medicinal Chemistry
Title: Photosensitive Precursors to Nitric Oxide
Volume: 5 Issue: 7
Author(s): Christopher M. Pavlos, Hua Xu and John P. Toscano
Affiliation:
Keywords: photodynamic therapy, diazeniumdiolate, nucleophiles, photolysis, meta substituents, photorelease
Abstract: The photochemistry and use of recently developed photosensitive precursors to nitric oxide (NO) are reviewed. As "caged NO" donors these precursors are able to deliver NO in a spatially and temporally controllable manner. These properties have made such precursors useful in applications in biology and medicine, especially in elucidating neurophysiological roles of NO and in new cancer therapies.
Export Options
About this article
Cite this article as:
Pavlos M. Christopher, Xu Hua and Toscano P. John, Photosensitive Precursors to Nitric Oxide, Current Topics in Medicinal Chemistry 2005; 5 (7) . https://dx.doi.org/10.2174/1568026054679326
DOI https://dx.doi.org/10.2174/1568026054679326 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nutrition Support of Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Current Nutrition & Food Science Patent Selections
Recent Patents on DNA & Gene Sequences Editorial Review of 2012
Current Radiopharmaceuticals PLGA Hollow Microbubbles Loaded with Iron Oxide Nanoparticles and Doxorubicin for Dual-mode US/MR Imaging and Drug Delivery
Current Nanoscience Aurora A and B Kinases - Targets of Novel Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Improving Cancer Therapeutics by Molecular Profiling
Current Drug Metabolism Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Thomsen-Friedenreich Disaccharide Immunogenicity
Current Cancer Drug Targets Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer
Current Pharmaceutical Design Synthesis and Characterization of Cu-SnO2 Nanoparticles Deposited on Glass Using Ultrasonic Spray Pyrolysis and their H2S Sensing Properties
Current Nanoscience Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019)
Recent Patents on Anti-Cancer Drug Discovery Graphical Abstracts
Current Drug Delivery The Therapeutic Potential of miR-7 in Cancers
Mini-Reviews in Medicinal Chemistry A Review of the Evidence for a Neuroendocrine Link Between Stress, Depression and Diabetes Mellitus
Current Diabetes Reviews Biological Activity of Carotenoids: Its Implications in Cancer Risk and Prevention
Current Pharmaceutical Biotechnology Myelodysplastic/Myeloproliferative Neoplasms
Current Cancer Therapy Reviews Recombinant Antibodies in Cancer Therapy
Current Protein & Peptide Science CMT-3, a Non-antimicrobial Tetracycline (TC), Inhibits MT1-MMP Activity: Relevance to Cancer
Current Medicinal Chemistry Turning to Computer-aided Drug Design in the Treatment of Diffuse Large B-cell Lymphoma: Has it been Helpful?
Anti-Cancer Agents in Medicinal Chemistry A Newly Synthetized Ferrocenyl Derivative Selectively Induces Apoptosis in ALL Lymphocytes through Mitochondrial Estrogen Receptors
Anti-Cancer Agents in Medicinal Chemistry